For the life sciences ecosystem to continue to thrive, leaders must reevaluate their operating environment and plan for key drivers this year. … READ MORE >
life sciences
Life sciences industry outlook: Spring 2022
Innovation and adaptation of life sciences in 2022 will be shaped by the major drivers of supply chain issues, human capital availability and capital markets. … READ MORE >
5 things to know in life sciences: Week of Jan. 31, 2022
From the rapid rise of a telehealth pharmacy to calls to increase clinical trial cost disclosures, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 24
From ethical questions for neurologists and clinical research to an omicron-focused vaccine, each week we highlight five things to know in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 17, 2022
From the impact of antimicrobial-resistant diseases to the demand for decentralized clinical trials, each week we highlight five things you need to know in the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of Jan. 10
This week we highlight a flood of studies and approvals with a focus on leveraging new technologies, data and gene sequencing to increase patient care. … READ MORE >
5 things to know in life sciences: Week of Jan. 3
This week we explore a partnership between a large biopharma and a machine learning startup along with other developments impacting the life sciences industry. … READ MORE >
Five things to know in life sciences: Week of Dec. 13
From eye drops that replace glasses to a new Pfizer facility focused on gene therapy, each week we highlight five things to know in life sciences. Here’s the latest. … READ MORE >
Five things to know in life sciences: Week of Dec. 6
From leadless pacemakers to a possible new Alzheimer’s treatment, each week we highlight five things impacting the life sciences industry. … READ MORE >
Five things we don’t know about omicron: Week of November 29
This week it is unavoidable not to mention omicron and so we’ve decided to dedicate our issue of “5 things in life sciences” to this very topic. … READ MORE >